Search

Author/Creator Han, SH

1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022)

Authors:
Verma, Subodh; Dhingra, Nitish K; Butler, Javed; Anker, Stefan D; Ferreira, Joao Pedro; Filippatos, Gerasimos; Januzzi, James L; Lam, Carolyn S P; Sattar, Naveed; Peil, Barbara; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; Packer, M; Anker, S; Butler, J; ...
Journal:
Lancet
Issue:
Volume 10:Issue 1(2022)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti‐tuberculosis treatment in HIV/tuberculosis‐coinfected patients: results from the TREAT Asia HIV Observational Database. Issue 2 (28th August 2013)

Authors:
Han, SH; Zhou, J; Lee, MP; Zhao, H; Chen, Y‐MA; Kumarasamy, N; Pujari, S; Lee, C; Omar, SFS; Ditangco, R; Phanuphak, N; Kiertiburanakul, S; Chaiwarith, R; Merati, TP; Yunihastuti, E; Tanuma, J; Saphonn, V; Sohn, AH; Choi, JY
Journal:
HIV medicine
Issue:
Volume 15:Issue 2(2014:Feb.)
Page Start:
77
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗